Pharmaceuticals News and Research

RSS

JAK genes and cancer

Cancer-causing genes can work in more powerful and sneaky ways than have been realized.

18 Sep 2007

Scientists synthesize DNA-based memory loop in yeast cells

Harvard Medical School researchers have successfully synthesized a DNA-based memory loop in yeast cells, findings that mark a significant step forward in the emerging field of synthetic biology.

17 Sep 2007

Solid state NMR spectroscopy reveals the workings of 'Mother Nature's Blowtorch'

Using atom-level imaging techniques, University of Michigan researchers have revealed important structural details of an enzyme system known as "Mother Nature's blowtorch" for its role in helping the body efficiently break down many drugs and toxins.

17 Sep 2007

Powerful new discovery method speeds up gene discovery

Scientists will be able to pinpoint genetic causes of human diseases faster than ever thanks to a powerful new discovery method unveiled by the Southwest Foundation for Biomedical Research (SFBR) and an international team of researchers.

17 Sep 2007

New green methods for coating drugs in plastics

Green chemistry is being employed to develop revolutionary drug delivery methods that are more effective and less toxic - and could benefit millions of patients.

13 Sep 2007

Study suggests brain tumors need treatment with multiple 'targeted' drugs

Researchers at Dana-Farber Cancer Institute have shown that several, rather than just one, cell-growth switches are simultaneously overactive in many brain tumors and other solid tumors, explaining why treatment with just a single "targeted" switch-blocking drug often yields disappointing results.

13 Sep 2007

Angiotech receives favourable patent decision from New Zealand

Angiotech Pharmaceuticals, Inc. announced today that it received a favourable decision from the Intellectual Property Office of New Zealand regarding an attempt by Johnson & Johnson's subsidiary, Conor Medsystems Inc. ("Conor") to revoke Angiotech's New Zealand Patent 523799, which pertains to compositions comprising a polymer and paclitaxel, as well as, generally, to paclitaxel-eluting stents.

13 Sep 2007

Novel angiogenic drugs could revolutionize treatment of peripheral arterial disease

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the market entry of novel angiogenic agents, including a future blockbuster drug from Genzyme, could revolutionize symptomatic treatment of peripheral arterial disease (PAD).

12 Sep 2007

No evidence that Aspartame non-nutritive sweetener causes cancer

A sweeping review of research studies of aspartame says there is no evidence that the non-nutritive sweetener causes cancer, neurological damage or other health problems in humans.

12 Sep 2007

Some GPs over-estimate adverse risks associated with the use of beta blocker drugs for heart disease

Some General Practitioners (GPs) over-estimate adverse risks associated with the use of beta blocker drugs in the fight against heart disease, according to research launched today at the British Pharmaceutical Conference (BPC) in Manchester.

11 Sep 2007

New gel to treat retinal diseases in development

New research presented at the British Pharmaceutical Conference (BPC) in Manchester shows that a new gel for under the eyelid could provide an innovative way of delivering drugs to treat age-related retinal diseases such as wet macular degeneration - potentially making some invasive eye injections a thing of the past.

11 Sep 2007

Micro-needles a safe alternative to hypodermic syringes

New research presented at the British Pharmaceutical Conference (BPC) in Manchester shows that micro-needles may be a safer and less painful method for delivering vaccines and other medicines traditionally administered using a hypodermic syringe.

11 Sep 2007

Project aims to reduce accidents and broken hips for older patients

Falls are one of the most common problems among elderly patients and are associated with fractures, reduced mobility and hospital admissions, and also lead to a loss of independence and confidence.

11 Sep 2007

$One in two women at high risk of bone fractures don't receive preventative treatment$

One in two women at high risk of bone fractures don't receive preventative treatment

One in two women at high risk of bone fractures don't receive preventative treatment, according to new research presented at the British Pharmaceutical Conference (BPC) in Manchester.

11 Sep 2007

Tangerine peel extract kills certain cancer cells

Research presented at the British Pharmaceutical Conference (BPC) in Manchester, shows that a compound extracted from tangerine peel can kill certain human cancer cells.

11 Sep 2007

Most chronic sinusitis cases are from fungal-induced inflamma

Accentia Biopharmaceuticals announces evidence that most, if not all cases of chronic sinusitis (CS), are due to a fungal-induced inflammation as originally proposed by investigators at the Mayo Clinic.

11 Sep 2007

Sanofi-aventis announces settlement of average wholesale price suits with DoJ relating to Anzemet

Sanofi-aventis announced today a civil settlement with the U.S. Department of Justice to resolve "Average Wholesale Price" (AWP) lawsuits under the federal False Claims Act relating to Anzemet(R) involving one of its predecessor companies, Aventis Pharmaceuticals Inc. (API).

11 Sep 2007